Palatin Technologies, Inc. (PTN)
5.52
-0.47
(-7.85%)
USD |
NASDAQ |
Oct 20, 16:00
5.60
+0.08
(+1.45%)
After-Hours: 20:00
Palatin Technologies Price : 5.52 for Oct. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 5.99 | 5.99 | 5.40 | 5.52 | 64641.00 |
| Oct 19, 2026 | 6.03 | 6.45 | 5.55 | 5.99 | 56384.00 |
| Oct 16, 2026 | 6.93 | 6.93 | 6.00 | 6.02 | 39200.00 |
| Oct 15, 2026 | 7.40 | 8.00 | 6.35 | 6.49 | 43423.00 |
| Oct 14, 2026 | 8.01 | 8.375 | 7.25 | 7.42 | 49251.00 |
| Oct 13, 2026 | 8.93 | 9.07 | 8.135 | 8.19 | 14212.00 |
| Oct 12, 2026 | 8.55 | 8.80 | 8.20 | 8.55 | 16989.00 |
| Oct 09, 2026 | 8.93 | 9.20 | 8.375 | 8.60 | 31439.00 |
| Oct 08, 2026 | 9.86 | 9.86 | 8.87 | 9.01 | 32471.00 |
| Oct 07, 2026 | 9.87 | 9.87 | 9.160 | 9.52 | 9019.00 |
| Oct 06, 2026 | 9.00 | 9.88 | 9.00 | 9.41 | 2765.00 |
| Oct 05, 2026 | 9.23 | 9.70 | 8.96 | 9.48 | 13007.00 |
| Oct 02, 2026 | 9.02 | 9.45 | 8.675 | 9.33 | 17288.00 |
| Oct 01, 2026 | 8.74 | 9.12 | 8.68 | 9.06 | 33048.00 |
| Sep 30, 2026 | 9.58 | 9.79 | 8.87 | 8.87 | 21516.00 |
| Sep 29, 2026 | 9.54 | 9.69 | 9.04 | 9.12 | 32880.00 |
| Sep 28, 2026 | 9.86 | 10.09 | 8.725 | 9.58 | 39296.00 |
| Sep 25, 2026 | 9.85 | 10.35 | 9.50 | 10.10 | 22381.00 |
| Sep 24, 2026 | 10.12 | 10.12 | 9.60 | 9.83 | 26519.00 |
| Sep 23, 2026 | 10.79 | 10.79 | 9.81 | 10.27 | 41213.00 |
| Sep 22, 2026 | 10.66 | 10.70 | 10.00 | 10.27 | 41664.00 |
| Sep 21, 2026 | 11.03 | 11.73 | 10.22 | 10.22 | 57775.00 |
| Sep 18, 2026 | 10.37 | 11.05 | 10.27 | 10.86 | 51558.00 |
| Sep 17, 2026 | 9.51 | 10.64 | 9.50 | 10.43 | 34201.00 |
| Sep 16, 2026 | 10.94 | 11.21 | 9.42 | 9.46 | 137450.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.44 |
| Alnylam Pharmaceuticals, Inc. | 230.71 |
| Anika Therapeutics, Inc. | 20.44 |
| Savara, Inc. | 4.76 |
| Vericel Corp. | 40.58 |
Price Related Metrics
| PS Ratio | 1.201 |
| Price to Book Value | 1.469 |
| Earnings Yield | -1.45% |
| Market Cap | 9.822M |